NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss – Better Plant Sciences Nov 19 • 5 min read Better Plant Sciences Inc. announced that its majority-owned subsidiary NeonMind Biosciences Inc. has now commenced a psilocybin preclinical trial examining psilocybin as a potential treatment to promote and cause weight loss and to reduce food cravings.
Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics Nov 18 • 5 min read Revive Therapeutics Ltd. announced it has entered into an exclusive research collaboration agreement with PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation.
Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program Nov 17 • 7 min read Field Trip Health Ltd. announced today that it plans to open a Field Trip Health Center in Amsterdam, Netherlands.
Navy SEAL Foundation Contributes $50,000 to Support Major PTSD Study Nov 16 • 6 min read The Navy SEAL Foundation pledged one of the organization’s largest single grants in its 20-year history to support a major Post Traumatic Stress Disorder (PTSD) study.
MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities Nov 16 • 8 min read MindMed has received a positive response on its protocol design for a Phase 2a clinical trial evaluating microdoses of LSD in the treatment of adult ADHD.